Yankees Score with ...
Health Care: Drugs
Eli Lilly and Company (LLY: NYSE)
$54.14 -0.60 | -1.10%
05/24/13 - 04:00 PM ET
Latest Dividend:0.49
Latest Dividend Yield:3.57%
Dividend Ex-Date:05/14/13
Price Earnings Ratio:13.17
Price Earnings Comparisons:
| LLY | Sector Avg. | S&P 500 |
|---|---|---|
| 13.17 | 13.20 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 0.87 | 34.60 | 65.28 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -6.90 | 0.04 | 0.01 |
| Net Income | 0.00 | 0.00 | |
| EPS | -6.20 | -0.07 | -0.02 |
Earnings for LLY:
| EBITDA | 6.48B |
| REVENUE | 22.60B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.00 | $0.94 | $3.91 | $2.75 |
| Number of Analysts | 8 | 7 | 12 | 10 |
| High Estimate | $1.05 | $0.98 | $3.96 | $2.90 |
| Low Estimate | $0.95 | $0.87 | $3.85 | $2.62 |
| Prior Year | $0.83 | $0.79 | $3.39 | $3.91 |
| Growth Rate (Year over Year) | 21.08% | 19.35% | 15.39% | -29.67% |
Portfolios with LLY
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- ProRenaissance Technologies
- Contributor8 Stocks With Big Dividends...
- ContributorStocks Rising On Unusual Vo...
- ContributorRocket Stocks for the Week ...
- UserJS&JH
- Contributor5 Bullish Stocks to Buy on ...
- UserBG Stockpickr Wish List
- UserStock Interests, Ideas & Re...
- Contributor7 High-Yield Stocks With Bu...
Latest LLY Headlines from TheStreet
- CAT, NFLX to Report in Week Ahead
04.19.13 | 03:04 pm - Eli Lilly Says Experimental Diabetes Drug Meets Goals 04.17.13 | 10:04 am
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) 04.16.13 | 10:04 am
- Eli Lilly And Company (LLY): Health Care's Featured Underperformer Of The Day 04.15.13 | 05:04 pm
- 5 Stocks Pulling The Drugs Industry Downward 04.12.13 | 01:04 pm
- Eli Lilly And Stock Hits New 52-Week High (LLY) 04.10.13 | 09:04 am
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) 04.03.13 | 10:04 am
- Eli Lilly And Reaches New 52-Week High (LLY) 04.02.13 | 10:04 am
- 5 Stocks Pulling The Health Care Sector Downward 04.01.13 | 01:04 pm
- Repros CEO: My Testosterone Drug Helped Gay Cubans Have Lots of Sex 03.28.13 | 12:03 pm
Press Releases for LLY
- From Research Labs To Doctors' Offices, Health Care Providers At Lilly Play Important Role In Bringing New And Innovative Medicines To Patients - PR Newswire 05.20.13 | 08:05 am
- Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint In Diffuse Large B-Cell Lymphoma - PR Newswire 05.10.13 | 08:05 am
- Retrospective Analysis Of Linagliptin Data In Sub-populations With Type 2 Diabetes Presented At AACE 22nd Annual Scientific & Clinical Congress - PR Newswire 05.06.13 | 06:05 pm
- Lilly Announces CEO Dr. John Lechleiter To Undergo Scheduled Surgery - PR Newswire 05.06.13 | 04:05 pm
- Lilly Declares Second-Quarter 2013 Dividend - PR Newswire 05.06.13 | 02:05 pm
- Boehringer Ingelheim Pharmaceuticals, Inc. And Eli Lilly And Company Launch Educational Campaign About Emerging Science In Type 2 Diabetes - PR Newswire 05.02.13 | 08:05 am
- Lilly Diabetes And Disney Publishing Worldwide Expand Collaboration - PR Newswire 04.30.13 | 08:04 am
- Lilly Celebrates National Volunteer Week With Deployment Of Global Service Teams - PR Newswire 04.26.13 | 07:04 am
- Lilly Again Named One Of DiversityInc's Top 50 Companies For Diversity - PR Newswire 04.24.13 | 11:04 am
- Lilly Acquires Novel Tau Tangle Diagnostic Program To Bolster Alzheimer's Disease Research And Development - PR Newswire 04.17.13 | 08:04 am
Partner Headlines for LLY
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Is the New Abbot a Winner? - Wall St. Cheat Sheet 04.02.13 | 10:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 6 Stocks To Accumulate For A High-Yield Stable Portfolio - Seeking Alpha 02.26.13 | 09:02 am
- 2013, A Year Of Turmoil For Eli Lilly - Seeking Alpha 02.16.13 | 09:02 am
- FDA rejects Novo Nordisk insulin remedy - Financial Times 02.12.13 | 12:02 am
- Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises - Investor's Business Daily 02.11.13 | 05:02 pm
- Novo Nordisk: reality check - Financial Times 02.11.13 | 04:02 pm
